Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Jan 27, 2022

How can we counsel patients about smoking cessation? In this interview, Dr. Joji Suzuki emphasizes the advantages of motivational interviewing and discusses some pharmacologic treatments, such as nicotine replacement therapies, varenicline, and bupropion.

Guest: Joji Suzuki, M.D.
Interviewer: Wegdan Rashad, M.D.
Hosts:...


Jan 22, 2022

This episode discusses the use of ECT for severely ill patients, including its benefits and limitations, as well as the use of ECT as a maintenance treatment.

Faculty: David Osser, M.D.
Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.


Jan 17, 2022

What was the difference among antipsychotics? Over 1 year, lurasidone caused no net weight gain, whereas olanzapine caused a gain of 10 pounds. Perphenazine was associated with a 2 lb. loss vs olanzapine's 9.5 lb. gain.

Faculty: Jim Phelps, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.


Jan 12, 2022

This episode discusses first- and second-generation antipsychotics during breastfeeding, including clozapine, the only psychiatric drug nearly always contraindicated.

Faculty: Lauren Osborne, M.D.
Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.


Jan 7, 2022

How effective is fluvoxamine in patients with COVID-19? A 2-week course of full-dose fluvoxamine decreased clinical deterioration in outpatients with symptomatic COVID-19 infection.

Faculty: Jim Phelps, M.D.
Hosts: Jessica Diaz, M.D.; Lorena RodrĂ­guez, M.D.